08/2020 - Analysis of CRISPR‐Cas9 screens identify genetic dependencies in melanoma

Targeting the MAPK signaling pathway has transformed the treatment of metastatic melanoma. CRISPR‐Cas9 genetic screens provide a genome‐wide approach to uncover novel genetic dependencies that might serve as therapeutic targets. Here, we analyzed recently reported CRISPR‐Cas9 screens comparing data from 28 melanoma cell lines and 313 cell lines of other tumor types in order to […]

Read more

07/2020 - In-cell architecture of an actively transcribing-translating expressome

In bacteria, RNA polymerases can associate with ribosomes to form transcription-translation units called expressomes. Multiple models based on structural data of in vitro reconstitution assays have been proposed for how the two machineries interface with one another. Understanding this bacteria-specific coupling mechanism offers insight regarding the central dogma of molecular biology and might be leveraged […]

Read more

07/2020 - Data mining application to healthcare fraud detection: a two-step unsupervised clustering method for outlier detection with administrative databases

Being the recipient for huge public and private investments, the healthcare sector results to be an interesting target for fraudsters. Nowadays, the availability of a great amount of data makes it possible to tackle this issue with the adoption of data mining techniques. This approach can provide more efficient control of processes in terms of […]

Read more

07/2020 - Drug mechanism‐of‐action discovery through the integration of pharmacological and CRISPR screens

Low success rates during drug development are due, in part, to the difficulty of defining drug mechanism‐of‐action and molecular markers of therapeutic activity. Here, we integrated 199,219 drug sensitivity measurements for 397 unique anti‐cancer drugs with genome‐wide CRISPR loss‐of‐function screens in 484 cell lines to systematically investigate cellular drug mechanism‐of‐action. We observed an enrichment for […]

Read more